PSA Rising - welcome!
  • PSA Rising Home | blog latest entry| newswire | forums | books | about

Join to add comments or your story

  • Register
  • Login
  • TOPICS
    • Prostate Cancer
    • Provenge
    • Taxotere
    • Nutrition
    • Drug Info
    • Satraplatin
    • Activism
    • Jobs, Work, Disability
    • QOL
    • Fatigue
    • Legal issues
    • COX-2 inhibitors
    • Health Insurance
    • Imclone - Erbitux
    • Cancer
    • Vitamin D3
    • African American
    • Medical Ethics
    • Pollution
    • Thalidomide
    • Death & Dying
    • Avastin
    • ED
    • Treatment choice
    • Proton beam
    • Herbal Medicine
    • BPH
    • ADT: androgen deprivation tx
    • treatment side effects
    • Acapodene
    • Clinical trials-open
    • Clinical trial results
    • Vaccines
    • Brachytherapy
    • Vitamin-Mineral Supplements
    • Phenoxodiol
    • RSS feeds
    • Metastastic
    • Survival
    • Stage
    • Genes
    • Chemotherapy
    • Breast
    • Ovarian
    • androgen independent/hormone refractory
    • ZK-Epo, Berlex Labs
    • Flurizan (MPC-7869) Myriad Genetics
    • Pain Management
  • Click to bookmark PSA Rising RSS feed.
    To bookmark our live headlines in your toolbar click the orange button. Or subscribe in a feed reader as supplied by these favorites services
    add to My Yahoo
    Add to Google Subscribe in NewsGator Online
  • LINKS
    • Cancer Journals

      • Cancer Research (an AACR journal)
      • Clinical Cancer Research (an AACR Journal
    • Cancer Research

      • AACR
    • Environmental Health

      • Environmental Health Perspectives
    • Healthcare, insurance

      • Metastar
      • BenefitsCheckUpRx
      • Medicare & Prescription Help
      • Medicare
      • Eldercare locator
    • Home

      • PSA Rising
    • Medical Ethics

      • The Hutch "UNINFORMED CONSENT"
    • Nutrition

      • Consumer Lab Reviews
      • Dietary Supplements Info
      • Food Routes
      • nutrition.org
      • The New Farm
    • Prostate Cancer

      • Being a Patient (New York Times)
      • Free Multigraph
      • Fatigue
      • Angiogenesis section at Nature, 12/05
      • Terry Van Dyke's Lab
      • FDA > Trelstar
      • Xinlay - FDA review docs
      • My Cancer Blog - Daniel
      • WARRIOR GORD'S PCD
      • GRUPO DE APOYO PARA EL CANCER DE PROSTATA
      • Living with prostate cancer, a patient blog
      • Spanish Cancer Association
      • Prostate Action: Campaign is the Aim (UK)
      • Cycle for Life
      • San Jose Prostate Cancer Support Group
      • Lions Australia Prostate Health
  • ARCHIVES
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • July 2006
    • June 2006
    • May 2006
    • April 2006
    • March 2006
    • February 2006
    • January 2006
    • December 2005
    • November 2005
    • September 2005
  • Valid XHTML
  • XFN


powered by FreeFind

advertising

Seven Steps download

Seven Keys to Treating Prostate Cancer. Johns Hopkins .pdf

New book!

Dr. Peter Scardino's Prostate Book
by Peter Scardino and Judith Kelman $18.45

Strum & Poliagno

A Primer on Prostate Cancer: The Empowered Patient's Guide
by Stephen Strum, MD & Donna Pogliano. Paperback, 1s edition. $19.98..

Prostate & Cancer Family Guide

Prostate & Cancer:
A Family Guide
to Diagnosis,
Treatment &
Survival

by Sheldon Marks MD Reference book for men concerned about or diagnosed with prostate cancer. $12.57

 

January 2007
S M T W T F S
« Dec    
 123456
78910111213
14151617181920
21222324252627
28293031  

June 23, 2006

COX-2 inhibitor plus radiation

category: Prostate Cancer, COX-2 inhibitors, Treatment choice posted by admin @ 12:09 pm

COX-2 inhibitors are a class of drugs that have been shown to have some anti-tumor activity against human prostate cancer, both in the lab and in tests on humans. German researchers wanted to find out if combining COX-2 inhibitors with radiation therapy causes more severe side effects than radiation alone. They conducted a Phase I trial to test this.
(full story…)

Comment (1)
• • •

April 3, 2006

NSAID anti-prostate cancer benefit confirmed

category: Prostate Cancer, COX-2 inhibitors posted by admin @ 6:33 am

In the past few years we have reported on a number of studies indicating that aspirin and other NSAIDs (non steroidal anti-inflammatory drugs) may protect men against prostate cancer. For example:

Use of aspirin or other NSAIDs increases survival for men with prostate cancer October 5, 2004.

But one study of NSAIDs and cancer turned out to be fake. In April 2005 Dr. Jon Sudbø reported at the annual meeting of American Association for Cancer Research in Anaheim, CA that NSAIDs prevent some cancers but increase cardiovascular deaths. His paper was published in a leading medical journal. But in January 2006 the entire study was revealed as a fake built from fabricated data.

Now a Canadian team has confirmed that men who take non-steroidal anti-inflammatory drugs may receive protection against prostate cancer.
(full story…)

Comment (0)
• • •

February 11, 2006

Omega-6 fatty acids hasten growth of prostate cancer cells

category: Prostate Cancer, Nutrition, COX-2 inhibitors, Cancer posted by admin @ 6:50 pm

2006-02-10 10:16:19 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Adding arachidonic acid, an omega-6 fatty acid, to culture media causes prostate cancer cells to grow twice as fast as usual, according to a report in the February 1st issue of Cancer Research.

“Investigating the reasons for this rapid growth, we discovered that the omega-6 was turning on a dozen inflammatory genes that are known to be important in cancer,” lead author Dr. Millie Hughes-Fulford, from the San Francisco VA Medical Center, said in a statement.

Further analysis indicated that arachidonic acid was activating these genes through a PI3-kinase pathway known to play a key role in the pathogenesis of cancer.

Adding an NSAID or a PI3-kinase inhibitor to the culture media blocked the arachidonic acid-induced proliferation of prostate cancer cells, the findings indicate.

In light of the current findings, Dr. Hughes-Fulford said she now avoids cooking with corn oil, which is known to be high in omega-6 fatty acids. “I’m not a physician, and do not tell people how to eat, but I can tell you what I do in my own home. I use only canola oil and olive oil.”

Cancer Research, Feb 1, 2006.
Arachidonic Acid Activates Phosphatidylinositol 3-Kinase Signaling and Induces Gene Expression in Prostate Cancer
Millie Hughes-Fulford1,2,3, Chai-Fei Li, Jim Boonyaratanakornkit and Sina Sayyah
Department of Veterans Affairs Medical Center; Northern California Institute for Research and Education; and University of California, San Francisco, California

News Source: Reuters Health

Comment (1)
• • •

January 17, 2006

Cancer research or virtual reality

category: COX-2 inhibitors, Cancer, Medical Ethics posted by admin @ 2:03 am

Follow up to the Oslo fabrication. Dr. Sudbø is not in hiding, but he is “on sick leave” and cannot be reached. His wife and his twin brother, who are both scientists, worked with him on the The Lancet study, according to the Guardian, but were unaware of his fraud.

No way of knowing as yet if any statements about the effect of NSAIDs on oral cancer in his article are true. It’s plain though that Dr. Sudbø assembled no genuine evidence for anything that he claimed in this study. He created a simulated reality, a database of pretend patients.
(full story…)

Comment (0)
• • •

January 16, 2006

Oslo cancer researcher admits to fabricating data

category: COX-2 inhibitors, Cancer, Medical Ethics posted by admin @ 3:52 am

Last April PSA Rising ran a brief report of a Norwegian study that claimed that “Non-steroidal anti-inflammatory drugs (NSAIDs) prevent some cancers but . . . the advantage from NSAID protection against oral cancer was wiped out by double the rate of heart attack or stroke.”

This weekend it was evident that this study of the effects of ibuprofen and naproxen on oral cancer was fabricated from A to Z.

Nested case-control study of effect of NSAIDs on oral cancer published in the Lancet, faked. Graphic from www.nrk.no

Norwegian hospital officials stated last week that the study was faked. Today, according to Reuters, the hospital in Oslo said: “A Norwegian cancer expert made up fictitious patients for an article about treatment of oral cancer published in a leading medical journal. . . .”

“The material was fabricated,” said Trine Lind, spokeswoman of the Norwegian Radium Hospital where Jon Sudbo has worked as a doctor and a researcher. “We are shocked. This is the worst thing that could happen in a research institution like ours.”

The hospital spokeswoman said Sudbo, 44, “invented patients and case histories for a study of oral cancer that was published in the British medical journal the Lancet in October 2005.”

The Lancet is Britain’s leading medical journal.

ANNE MARTE BLINDHEIM in the Norwegian daily Dagbladet reported Friday Frykter norsk lege har jukset før that “250 of his sample of 908 people in the study all shared the same birthday,” Reuters said.

Stein Vaaler [photographed below], strategy director for the Oslo cancer center, said: “A colleague raised questions about the article when it was published,” and (according to reports by Canadian CTV and Associated Press ( Cancer researcher admits to fabricating data) “when the researcher was confronted this week about the data, he acknowledged the fabrication, Vaaler said.”

Norwegian media are calling the situation “a personal tragedy.”

Stein Vaaler, Strategy director, Radium Hospital, Oslo; photo: dagbladet.no

“All of it was fabricated,” Vaaler said. “It was not manipulation of real data — it was just complete fabrication.”
(full story…)

Comment (0)
• • •

December 22, 2005

Saving Celebrex

category: Prostate Cancer, COX-2 inhibitors posted by admin @ 1:33 am

Forbes has a story this month about a Cox-II inhibitor, Celebrex. While mostly used for arthritis pain, this drug is of high interest to cancer patients as a possible tumor inhibitor (for background on the cancer connection see
Cancer Patients … and Celebrex in Anti-Cancer Trials Nov 2004
(full story…)

Comment (1)
• • •
PSA Rising: http://www.psa-rising.com© 1997-2007.